glp-1 cgm GLP-1-based therapies for type 2 diabetes: from single, dual and triple agonists to endogenous production and L-cell differentiation | Diabetology & Metabolic Syndrome GLP-1 drugs are already famous

and (right) the discontinuation of Tensilon following regulatory actions, reflecting its reduced use and replacement by more reliable modern diagnostics such as antibody assays and genetic testing

Yet, amidst the chatter, it's not uncommon to find a haze of confusion

Older adults past their mid-30s and 40s, simply because natural production tends to taper

Treatment is subcutaneous and prescribed within a monitored cycle

Regulatory timelines suggest more effective oral options are on the horizon

And for those on a GLP-1, "higher fat, greasy, heavy foods tend to cause more of the nausea, upset stomach and potential vomiting in these patients," Nadolsky says